Internal Medicine, Hematology & Oncology · Norman, OK
NPI
1346561495
Since 2010
Specialty
Internal Medicine, Hematology & Oncology
Code 207RH0003X
Group practices
1
Medicare group memberships
Hospitals
2
Hospital affiliations
701 E Robinson St, Suite 100
Norman, OK, 73071
Phone (405) 321-4644
Groups this clinician bills Medicare through
Medicare paid, 2024
$86K
924 services
Medicare patients, 2024
345
Average age 75
Drug cost, 2024
$3.1M
1,178 prescriptions
Company payments, 2025
$766
From 10 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Namali Pierson was code 99215 (office e&m - established), 494 times for 125 patients. In total Namali Pierson billed 924 services in 8 codes, and Medicare paid $86K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2016-07-12.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99215 Office E&M - Established | Office | 494 | 125 | $104.65 | $52K |
| 99214 Office E&M - Established | Office | 289 | 185 | $67.53 | $20K |
| 99204 Office E&M - New | Office | 41 | 41 | $97.61 | $4,002 |
| 99205 Office E&M - New | Office | 31 | 31 | $129.84 | $4,025 |
| 99223 Hospital E&M - Initial | Facility | 28 | 23 | $135.03 | $3,781 |
| 99213 Office E&M - Established | Office | 24 | 23 | $45.23 | $1,085 |
By year: 2022 $111K for 1,205 services; 2023 $95K for 1,079 services; 2024 $86K for 924 services.
Medicare prescription drug claims, 2024
In 2024, the drug Namali Pierson prescribed most often to Medicare patients was Letrozole, with 191 prescriptions and refills. In total Namali Pierson wrote 1,178 Medicare prescriptions that cost $3.1M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Letrozole Generic | 191 | 438 | 48 | $4,663 |
| Levothyroxine Sodium Generic | 61 | 99 | 13 | $515 |
| Eliquis Apixaban | 58 | 68 | 11 | $39K |
| Oxycodone Hcl Generic | 51 | 51 | 26 | $908 |
| Prochlorperazine Maleate Generic | 50 | 50 | 27 | $507 |
| Ondansetron Hcl Generic | 44 | 44 | 31 | $425 |
| Acyclovir Generic | 39 | 45 | Under 11 | $269 |
| Anastrozole Generic | 34 | 100 | Under 11 | $737 |
| Gabapentin Generic | 31 | 35 | Under 11 | $419 |
| Pantoprazole Sodium Generic | 27 | 43 | Under 11 | $293 |
| Calquence Acalabrutinib Maleate | 27 | 27 | Under 11 | $340K |
| Droxia Hydroxyurea | 25 | 37 | Under 11 | $1,142 |
| Venlafaxine Hcl Er Venlafaxine Hcl | 20 | 36 | Under 11 | $200 |
| Alendronate Sodium Generic | 19 | 40 | Under 11 | $93.61 |
| Tramadol Hcl Generic | 19 | 19 | Under 11 | $136 |
Brand drugs: 339 claims; generic drugs: 839 claims; opioid claims: 108.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Namali Pierson $766 ($766 in general payments such as food, travel and fees) from 10 companies. The largest payer was Novartis Pharmaceuticals Corporation with $284.
| Company | Payments | Amount |
|---|---|---|
| Novartis Pharmaceuticals Corporation NVS | 6 | $284 |
| Abbvie Inc. ABBV | 9 | $163 |
| Merck Sharp & Dohme LLC MRK | 3 | $78.63 |
| GlaxoSmithKline, LLC. GSK | 4 | $64.55 |
| Lilly USA, LLC LLY | 3 | $47.05 |
| Astellas Pharma US Inc 4503.T | 2 | $36.82 |
| Daiichi Sankyo Inc. 4568.T | 1 | $29.06 |
| Sumitomo Pharma America, Inc. 4506.T | 1 | $24.65 |
| Celgene Corporation BMY | 1 | $21.28 |
| Adc Therapeutics America, Inc. | 1 | $16.29 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.